Suven Life Sciences Limited Share Price NSE India S.E.
Equities
SUVEN
INE495B01038
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111.4 INR | -1.89% | +4.99% | +38.02% |
Sales 2022 | 120M 1.43M 115M | Sales 2023 | 136M 1.63M 131M | Capitalization | 10.57B 127M 10.15B |
---|---|---|---|---|---|
Net income 2022 | -1.22B -14.63M -1.17B | Net income 2023 | -1.18B -14.19M -1.14B | EV / Sales 2022 | 109 x |
Net cash position 2022 | 472M 5.66M 454M | Net cash position 2023 | 2.27B 27.21M 2.18B | EV / Sales 2023 | 61.1 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-7.31
x | Employees | 132 |
Yield 2022 |
1.08% | Yield 2023 |
-
| Free-Float | 28.95% |
Latest transcript on Suven Life Sciences Limited
1 day | -1.89% | ||
1 week | +4.99% | ||
Current month | +11.45% | ||
1 month | +11.45% | ||
3 months | +2.62% | ||
6 months | +77.05% | ||
Current year | +38.02% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 08/03/89 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 09/01/20 |
Shrenik Soni
CMP | Compliance Officer | - | 09/01/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 08/03/89 | |
Sudha Rani Jasti
FOU | Founder | 70 | 08/03/89 |
Director/Board Member | 70 | 29/04/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 111.4 | -1.89% | 169,884 |
25/04/24 | 113.6 | +1.02% | 558,699 |
24/04/24 | 112.4 | +5.00% | 236,641 |
23/04/24 | 107.1 | +2.93% | 480,657 |
22/04/24 | 104 | -1.98% | 246,614 |
Delayed Quote NSE India S.E., April 26, 2024 at 12:43 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 530239 Stock
- SUVEN Stock